The Russian defense Ministry announced the beginning of clinical trials of the Russian vaccine against coronavirus. Testing will take place on volunteers from among the selected soldiers. About it reports “Interfax” with reference to the statement.
All selected already 50 soldiers, including five women. He voluntarily decided to participate in the testing, said the Ministry of defense of the Russian Federation.
The tests on the basis of the 48th Central research Institute of the Ministry of defense. The first group of volunteers will arrive in a special medical institution at the Institute on 3 June.
The Agency says that in may at the National research center of epidemiology and Microbiology of the Ministry of health staff informally experienced vectored vaccine COVID-19. According to the Director of the center Alexander Ginzburg, the experiment was a success: the adverse effects of vaccination allegedly was observed from the grafted developed immunity.
Gunzburg explained that we are talking about a vector vaccine based on adenovirus DNA which has the gene of the coronavirus SARS-CoV-2. Adenovirus is used as a “container” to deliver coronavirus gene in a cell, start there protein synthesis shell of a new coronavirus and to introduce thus the immune system with a potential enemy.
The defense Ministry plans to complete clinical trials of the vaccine until the end of July.
The world health organization believe that the coronavirus would pose a serious threat, until they invent a vaccine. According to the head of the European Agency of medicines Marco Kavaleri, in the best case, the vaccine will be ready next year.